Cases of the respiratory illness are rising in January 2026 across the state, including in the Sacramento area.

A new shot is helping protect more babies from RSV. A Dayton doctor said it is already dramatically reducing hospitalizations ...

A single dose of the recombinant respiratory syncytial virus (RSV) vaccine demonstrates effectiveness against infections and associated hospitalizations in veterans aged 60 years or older during the ...

RSV is a leading cause of infant hospitalizations, but prevention shots approved in 2023 have sharply reduced severe illness.

“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...

Researchers in France conducted a multicentre test‑negative case-control study to evaluate the effectiveness of nirsevimab in preventing RSV‑associated bronchiolitis at paediatric emergency ...

New year, new sickness? No, not quite. While there is a whole host of viruses going around, there are thankfully no new viruses to fret about − the ones we have are bad enough. Before 2024 closed out, ...

A systematic review and meta-analysis finds that the definition of severe acute respiratory infection (SARI) used by the ...

It’s beginning to look a lot like sick season. From cold and flu to stomach viruses and even RSV, germs are being spread around Georgia. The Georgia Department of Public Health provides a weekly flu ...

• RSV is the leading cause of infant hospitalization in the U.S. • Health officials urge vaccination for pregnant women, seniors, and people with medical risks. • Cases are climbing nationwide as flu ...

An estimated 29% of infants born from October 2023 to March 2024 were immunized against RSV. Preliminary data showed the immunization rate rose to 57% of infants born from April 2024 to March 2025.

The United States is fighting a "quad-demic" this winter with four major viruses—COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus—with infants at particular risk, Dr. Ryan Fulton ...